Bioinformatics analysis showed that MMP-9 was associated with survival and tumour function in patients with head and neck cancer, suggesting that MMP-9 may be a saliva-based noninvasive diagnostic biomarker and a prognostic therapeutic target for OSCC. The gene discussed is MMP9; the disease is head and neck cancer.